Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken

This publication has 22 references indexed in Scilit:

• Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo
  International Immunopharmacology, 2007
• Adjuvant Effects of Bacillus Calmette–Guerin DNA or CpG‐oligonucleotide in the Immune Response to Taenia solium Cysticercosis Vaccine in Porcine
  Scandinavian Journal of Immunology, 2007
• Vaccination with Newcastle disease vaccine and CpG oligodeoxynucleotides induces specific immunity and protection against Newcastle disease virus in SPF chicken
  Veterinary Immunology and Immunopathology, 2007
• A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells
  Journal of Hepatology, 2006
• A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy
  Vaccine, 2006
• Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo
  Developmental & Comparative Immunology, 2006
• Bacterial DNA Induces Murine Interferon-γ Production by Stimulation of Interleukin-12 and Tumor Necrosis Factor-α
  Cellular Immunology, 1996
• CpG motifs in bacterial DNA trigger direct B-cell activation
  Nature, 1995
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  Journal of Experimental Medicine, 1991
• Virally induced modulation of murine IgG antibody subclasses.
  Journal of Experimental Medicine, 1988